Valuation: Repligen Corporation

Market Cap 7.73B 6.77B 6.25B 5.83B 10.98B 731B 11.23B 75.17B 29.02B 360B 29.02B 28.38B 1,251B P/E 2026 *
126x
P/E 2027 * 76.3x
Enterprise Value 7.47B 6.54B 6.04B 5.64B 10.62B 707B 10.86B 72.7B 28.06B 349B 28.07B 27.45B 1,210B EV / Sales 2026 *
9.19x
EV / Sales 2027 * 7.72x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day-6.81%
1 week+8.24%
Current month+10.53%
1 month+10.53%
3 months+24.41%
6 months-17.34%
Current year-16.39%
1 week 127.18
Extreme 127.175
149.05
1 month 117.59
Extreme 117.59
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Chief Financial Officer

-733 0.0013%
05-14Free

Director

3,234 0.0057%
05-14Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-6.81%+8.24%+10.88%-1.03% 7.73B
-1.50%+5.56%-31.01%-13.89% 161B
-0.06%+2.09%-5.92%-6.73% 104B
-1.57%+3.82%-5.93%+47.83% 54.8B
+0.56%-2.02%+51.27%+51.98% 53.31B
-0.47%+10.29%-9.17%-40.43% 42.76B
+1.90%+14.12% - - 33.49B
-0.23%+1.32%-18.94%-45.30% 27B
+1.09%+7.57%+62.05%-6.01% 25.06B
-1.13%+6.41%-10.70%-3.51% 20.78B
Average -0.82%+5.91%+4.72%-1.90% 53B
Weighted average by Cap. -0.60%+4.75%-5.44%-1.47%

Financials

2026 *2027 *
Net sales 814M 712M 658M 614M 1.16B 76.92B 1.18B 7.91B 3.06B 37.95B 3.06B 2.99B 132B 945M 828M 764M 713M 1.34B 89.35B 1.37B 9.19B 3.55B 44.08B 3.55B 3.47B 153B
Net income 61.09M 53.49M 49.38M 46.11M 86.81M 5.78B 88.78M 594M 229M 2.85B 229M 224M 9.89B 101M 88.59M 81.78M 76.37M 144M 9.57B 147M 984M 380M 4.72B 380M 372M 16.38B
Net Debt -254M -223M -206M -192M -362M -24.06B -370M -2.47B -955M -11.87B -955M -935M -41.2B -432M -378M -349M -326M -614M -40.83B -628M -4.2B -1.62B -20.14B -1.62B -1.59B -69.93B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
29/06/26 US$137.00 -6.81% 1,802,598
26/06/26 US$147.01 +1.23% 1,966,213
25/06/26 US$145.23 +4.93% 1,963,027
24/06/26 US$138.40 +9.52% 1,421,051
23/06/26 US$126.37 -0.16% 856,499
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
137.00USD
Average target price
176.11USD
Spread / Average Target
+28.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock